What is the threshold score for gout classification?

A total score of 8 or more points (out of a possible 23) classifies the patient as having gout, provided the entry criterion of at least one episode of peripheral joint or bursal swelling, pain, or tenderness is met.

What is the sufficient criterion for gout diagnosis?

Identification of monosodium urate (MSU) crystals in synovial fluid from a symptomatic joint or bursa, or in a tophus, is sufficient alone to classify gout — no further point scoring is needed if crystals are confirmed.

Why does the criteria set include a negative score for low serum urate?

Serum urate under 4 mg/dL scores -4 points because gout is genuinely unlikely at such a low level — urate below this threshold makes the crystal deposition process that causes gout physiologically improbable, so it meaningfully argues against the diagnosis rather than simply contributing zero.

What joint is most classically involved in gout?

The first metatarsophalangeal joint (MTP1), causing the classic presentation known as podagra — sudden, severe pain, swelling, and redness of the big toe. MTP1 involvement scores the highest points (2) in the joint pattern domain.

Can gout be diagnosed without a joint aspiration?

Yes. While synovial fluid crystal analysis is the diagnostic gold standard and sufficient alone, the points-based criteria allow classification using clinical features, serum urate, and optionally imaging when aspiration isn't feasible or is negative.

What is the double-contour sign on ultrasound?

An irregular hyperechoic (bright) band along the surface of articular cartilage, representing urate crystal deposition on the cartilage surface. It's a specific ultrasound finding for gout and contributes 4 points to the imaging domain if present.

How is a tophus identified clinically?

A tophus is a firm, often chalky-white or yellowish subcutaneous nodule caused by urate crystal deposition, sometimes visible through thin overlying skin, typically located over extensor surfaces, the olecranon bursa, or the helix of the ear. Its presence scores 4 points.

Should serum urate be measured during an acute gout flare?

Ideally not for classification purposes — urate can be transiently normal or low during an acute attack. The criteria recommend measuring urate when the patient is asymptomatic and, ideally, off urate-lowering therapy and at least 4 weeks from flare onset for the most representative value.

What does a synovial fluid analysis negative for MSU crystals mean for the score?

It subtracts 2 points from the total, reflecting that a genuinely negative crystal analysis in a symptomatic joint argues against gout, though sampling limitations and crystal-reading experience can occasionally produce false negatives.

Do these criteria rule out septic arthritis?

No. The gout classification criteria assess the likelihood of gout specifically and don't address infection. Any joint where septic arthritis is a genuine concern should have synovial fluid sent for Gram stain and culture regardless of the gout classification score, since the two conditions can occasionally coexist.

What's the maximum possible score on the gout classification criteria?

23 points, achieved with maximum points across joint pattern, episode characteristics, time course, tophus, serum urate, and both imaging findings. In practice, most classified patients score well above the 8-point threshold without needing every domain maximized.

Online Medical Tools — Gout Criteria (ACR/EULAR)

Printed on 9/4/2026

For informational purposes only. This is not medical advice.

Rheumatology

Gout Criteria (ACR/EULAR)

The 2015 ACR/EULAR Gout Classification Criteria provide a structured, points-based framework for classifying gout in patients with at least one episode of peripheral joint or bursal swelling, pain, or tenderness. Identification of monosodium urate (MSU) crystals on synovial fluid analysis is sufficient alone for classification; otherwise, clinical pattern, episode characteristics, time course, tophus presence, serum urate, synovial fluid analysis, and imaging findings are scored and summed, with a threshold of 8 points. Before treating an acute flare, rule out septic arthritis, especially in a hot, monoarticular joint — see CRP/ESR trends via Anion Gap and check renal function with eGFR, since kidney function drives urate-lowering therapy dosing and gout risk itself. If joint symptoms are polyarticular and symmetric rather than the classic monoarticular gout pattern, compare against RA Classification Criteria.

Formula: Clinical (joint pattern 0-2, episode characteristics 0-3, time course 0-2, tophus 0/4) + Laboratory (urate -4 to +4, synovial fluid MSU-negative -2) + Imaging (urate deposition 0/4, erosion 0/4). Total ≥8 = gout. MSU crystals alone = sufficient.

Entry Criterion: ≥1 episode of swelling, pain, or tenderness in a peripheral joint/bursa

MSU Crystals Identified (synovial fluid or tophus)

Joint/Bursa Pattern (ever)

Episode Characteristics (erythema; can't bear touch; difficulty walking)

Time Course (onset <24h, resolution ≤14d, complete resolution between episodes)

Clinical Evidence of Tophus

Serum Urate (uricase method)

Synovial Fluid Analysis: MSU-Negative

Imaging: Urate Deposition (US double-contour or DECT)

Imaging: Gout-Related Erosion (X-ray hands/feet)

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Confirm the entry criterion and check for the sufficient criterion (MSU crystals)

The 2015 ACR/EULAR Gout Classification Criteria apply only to patients who meet the entry criterion: at least one episode of swelling, pain, or tenderness in a peripheral joint or bursa. Without this, the criteria don't apply at all. Once met, check the sufficient criterion first: if monosodium urate (MSU) crystals are identified on polarized light microscopy of synovial fluid from a symptomatic joint, bursa, or tophus, this alone is enough to classify the patient as having gout — no further scoring across the clinical, laboratory, or imaging domains is needed. MSU crystal identification remains the diagnostic gold standard because it's directly visualizing the causative pathology (negatively birefringent, needle-shaped crystals), rather than inferring the diagnosis from an indirect clinical and laboratory pattern. If synovial fluid aspiration isn't feasible or crystals aren't found, proceed to the points-based scoring in the next step.

Score clinical, laboratory, and imaging domains when MSU crystals aren't confirmed

When crystal confirmation isn't available or is negative, score across eight items in three categories. Clinical domain: joint/bursa pattern (MTP1 involvement scores 2, ankle/midfoot without MTP1 scores 1), episode characteristics (erythema over the joint, can't bear touch or pressure, and significant difficulty walking or using the joint — 1 point per characteristic present, up to 3), time course (recurrent typical episodes — rapid onset within 24 hours, resolution within 14 days, complete symptom resolution between episodes — score 2 for recurrent, 1 for a single typical episode), and clinical tophus (a draining or chalk-like subcutaneous nodule under transparent skin, often over extensor surfaces, elbows, or ears — scores 4 if present). Laboratory domain: serum urate measured by a uricase-based method, ideally when the patient is not on urate-lowering therapy and at least 4 weeks from the start of the flare (urate can transiently drop during an acute attack) — scoring ranges from -4 points for urate under 4 mg/dL (makes gout unlikely) up to +4 points for urate ≥10 mg/dL. Synovial fluid analysis showing MSU-negative crystals (if fluid was analyzed but no crystals found) subtracts 2 points.

Add imaging findings and classify against the ≥8 point threshold

Imaging domain contributes two possible findings, each worth 4 points if present: evidence of urate deposition on ultrasound (the double-contour sign — an irregular hyperechoic band over the articular cartilage surface) or dual-energy CT (DECT, which can directly visualize urate deposits color-coded distinctly from calcium), and evidence of gout-related joint damage on conventional radiography (at least one erosion in the hands or feet). Neither imaging modality is required to apply the criteria — they're optional but can push a borderline score over threshold. Sum all domain points (clinical + laboratory + imaging, with the synovial fluid MSU-negative penalty subtracted if applicable) for a total possible range of -6 to 23. A total score of 8 or more classifies the patient as having gout. Scores below 8 don't rule out gout — especially if urate testing, imaging, or synovial fluid analysis wasn't performed — but indicate the available evidence doesn't yet meet the classification threshold.

Who Uses the Gout Criteria (ACR/EULAR)

Acute Monoarticular Arthritis in the Emergency Department

Emergency physicians evaluating a hot, swollen joint

Apply these criteria alongside a septic arthritis risk assessment for any acutely swollen, painful joint — a high gout classification score with classic MTP1 (podagra) involvement and typical rapid-onset time course supports gout, but joint aspiration to rule out infection remains essential whenever septic arthritis can't be confidently excluded, since the two can occasionally coexist.

Primary Care Diagnosis Without Access to Synovial Fluid Analysis

Primary care physicians and internists

When arthrocentesis isn't readily available or feasible (e.g., a small, hard-to-aspirate joint), the points-based clinical, laboratory, and imaging criteria offer a validated alternative path to classification using history, exam, serum urate, and potentially ultrasound imaging alone.

Urate-Lowering Therapy Initiation Decisions

Rheumatologists and primary care managing recurrent gout

A confirmed gout classification, combined with recurrent flares, tophi, or urate nephrolithiasis, supports initiating long-term urate-lowering therapy (allopurinol, febuxostat) per ACR gout management guidelines, which recommend treat-to-target serum urate below 6 mg/dL (or below 5 mg/dL with tophi).

Distinguishing Gout From Pseudogout and Other Crystal Arthropathies

Rheumatology consultants evaluating recurrent crystal arthritis

Scoring the specific joint pattern (MTP1 strongly favors gout, while knee and wrist involvement is more typical of calcium pyrophosphate deposition disease) alongside serum urate and imaging helps differentiate gout from pseudogout when synovial fluid crystal analysis is inconclusive or unavailable.

Clinical Trial Enrollment for Gout Therapeutics

Clinical research coordinators in gout drug trials

Modern gout trials use the 2015 ACR/EULAR criteria for standardized enrollment, ensuring a consistent, validated diagnostic threshold across study sites rather than relying on inconsistent clinical impression alone.

Pro Tips

MSU crystal identification always takes priority — check it first before scoring anything else

If synovial fluid analysis is feasible and shows MSU crystals, you're done — this is diagnostic on its own regardless of serum urate level (which can be misleadingly normal or even low during an acute flare) or any other clinical feature. Don't let a normal serum urate during an acute attack override a positive crystal analysis.

Serum urate can be falsely normal or low during an acute flare — retest 2-4 weeks later if borderline

Urate levels transiently drop during acute gout attacks in a meaningful proportion of patients, likely from urate's acute-phase uricosuric effects and cytokine-mediated renal excretion changes. A single normal urate during a flare doesn't rule out gout — for the most accurate classification-criteria scoring, retest when the patient is asymptomatic and at least 4 weeks from flare onset, ideally off urate-lowering therapy.

MTP1 (podagra) involvement is the single most classic and highest-weighted clinical clue

First metatarsophalangeal joint involvement is present in about 50-70% of first gout attacks and up to 90% of patients at some point in their disease course — its high specificity is reflected in its 2-point weighting versus 1 point for ankle/midfoot involvement without MTP1.

Don't skip imaging just because it's optional — ultrasound can resolve borderline scores efficiently

For a patient scoring 5-7 points from clinical and lab findings alone (just under the 8-point threshold), a point-of-care ultrasound showing the double-contour sign adds 4 points and can push classification over threshold without needing joint aspiration, particularly useful for small or difficult-to-aspirate joints.

Tophi can be subtle — look at the helix of the ear, olecranon bursa, and finger pad extensor surfaces

Chronic tophaceous gout deposits aren't always the classic large, draining nodule — early or small tophi can appear as firm, slightly yellow-white subcutaneous nodules, sometimes visible through thin skin over the ear helix or finger extensor tendons, and are easy to miss on a cursory exam.

A negative synovial fluid crystal analysis actively subtracts points — don't skip aspiration assuming a scored diagnosis is enough

If fluid was analyzed and no MSU crystals were found, this scores -2 points rather than 0, reflecting that a truly negative tap in a symptomatic joint meaningfully argues against gout (though sampling error and inexperienced crystal reading can produce false negatives, so clinical correlation still matters).

These criteria classify gout — they don't rule out coexisting septic arthritis

Gout and septic arthritis can occasionally coexist, and a high gout classification score should never substitute for synovial fluid Gram stain and culture in a joint where infection is a genuine concern (fever, marked leukocytosis, immunocompromise, or an atypically severe presentation) — always send fluid for both crystal analysis and culture when infection can't be confidently excluded.

Common Questions About Your Results

A urate of 5.5 mg/dL falls in the 4 to <6 mg/dL range, which scores 0 points (neutral) rather than negative — it doesn't argue strongly against gout, and a substantial minority of patients have normal or even low urate during an acute attack due to acute-phase uricosuric shifts. If the clinical picture (MTP1 involvement, rapid onset, erythema, recurrent typical episodes) is otherwise strongly suggestive, don't let a single mid-range urate value override it — consider retesting 2-4 weeks after the flare resolves for a more representative baseline value.

Yes. Imaging is optional and adds points when available, but plenty of patients can reach the ≥8 threshold from clinical features, serum urate, and synovial fluid analysis alone — for example, MTP1 involvement (2) + 2 episode characteristics (2) + recurrent typical episodes (2) + serum urate 8-10 mg/dL (3) already totals 9 points without any imaging. Reserve imaging for genuinely borderline cases where the score falls just short of threshold.

Score conservatively based on what can be reliably established — if the patient is uncertain about erythema but clearly recalls being unable to bear any touch or weight on the joint, score that one characteristic confidently and don't count the uncertain one. Photos from a prior flare (many patients now have phone photos of a red, swollen toe) can be genuinely useful for retrospectively confirming erythema when memory is unclear.

The criteria note that serum urate should ideally be measured when the patient is NOT on urate-lowering therapy for the most accurate classification scoring, since treatment artificially lowers urate independent of underlying gout severity. If the patient was already diagnosed and started on treatment before this assessment, rely more heavily on the clinical domain (joint pattern, episode characteristics, time course) and prior documented flares/crystal results rather than the current on-treatment urate level, which will understate the domain's true contribution.

They can be applied to a first episode — the entry criterion only requires one episode of joint/bursa swelling, pain, or tenderness. However, the time-course domain (worth up to 2 points for recurrent typical episodes) can only score 1 point maximum for a single typical episode, so first presentations may score somewhat lower on this domain than patients with an established pattern of recurrent attacks, making MSU crystal confirmation or imaging relatively more valuable for first-attack classification.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

MSU crystal identification alone is sufficient for gout classification. Otherwise, sum points across clinical, laboratory, and imaging domains — a total of 8 or more out of 23 classifies gout. Scores below 8 don't rule out gout, particularly if urate testing, synovial fluid analysis, or imaging wasn't performed.

When to Use This Tool

Use these criteria when evaluating a patient with at least one episode of peripheral joint or bursal swelling, pain, or tenderness to formally classify gout, particularly when synovial fluid crystal analysis is unavailable, not feasible, or was negative despite a suggestive clinical picture.

Limitations

The criteria classify gout but don't exclude coexisting septic arthritis, which should always be considered separately when infection is a clinical concern. Serum urate can be misleadingly normal during an acute flare, and imaging findings require ultrasound or DECT expertise not universally available.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools